Document Detail

Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells.
MedLine Citation:
PMID:  22382328     Owner:  NLM     Status:  In-Data-Review    
Caffeine is thought to increase the antitumor effect of cisplatin or DNA-damaging agents because it is known that caffeine inhibits DNA repair. Caffeine-assisted chemotherapy has been used in the treatment of osteosarcomas. In addition, there are several reports about combination chemotherapy with caffeine for certain malignancies other than osteosarcomas. However, there are no reports that show the utility of combination chemotherapy with caffeine for hepatocellular carcinoma (HCC). We examined the combined effects of caffeine and cisplatin in human HCC cell lines, and screened for a more effective administration method of caffeine in vitro. Human HCC cell lines (HepG2, HLF, HuH-7, and Li-7) were exposed to caffeine (0-0.5 mM) and cisplatin (0-1.2 μg/mL) for 72 h, either alone or in combination. Cell numbers were measured by WST-8 assay, and cell apoptosis was determined by annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) binding assay. As a result, caffeine increased the antitumor effect of cisplatin on cell proliferation and cell apoptosis in the HCC cell lines. Moreover, this effect was dependent on the amount of exposure to caffeine. These results suggest that caffeine-assisted chemotherapy is useful for HCC treatment.
Yohei Kawano; Masashi Nagata; Takafumi Kohno; Akihiro Ichimiya; Tomomi Iwakiri; Manabu Okumura; Kazuhiko Arimori
Related Documents :
9034128 - Activins and activin receptors in cell growth.
22382328 - Caffeine increases the antitumor effect of cisplatin in human hepatocellular carcinoma ...
11725828 - Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte gro...
1660868 - Secretion of polypeptides related to epidermal growth factor and insulinlike growth fac...
18810318 - Origin of pancreatic endocrine cells from biliary duct epithelium.
10569618 - Two mutations identified in the androgen receptor of the new human prostate cancer cell...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biological & pharmaceutical bulletin     Volume:  35     ISSN:  1347-5215     ISO Abbreviation:  Biol. Pharm. Bull.     Publication Date:  2012  
Date Detail:
Created Date:  2012-03-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9311984     Medline TA:  Biol Pharm Bull     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  400-7     Citation Subset:  IM    
Department of Pharmacy, University of Miyazaki Hospital.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, ...
Next Document:  Restriction of Mast Cell Proliferation through Hyaluronan Synthesis by Co-cultured Fibroblasts.